Compare SCLX & MLGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SCLX | MLGO |
|---|---|---|
| Founded | 2011 | 2018 |
| Country | United States | China |
| Employees | 34 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 48.5M | 44.0M |
| IPO Year | N/A | 2020 |
| Metric | SCLX | MLGO |
|---|---|---|
| Price | $6.48 | $4.34 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 92.4K | ★ 92.9K |
| Earning Date | 04-10-2026 | 04-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | ★ $87,132,230.00 |
| Revenue This Year | $122.52 | N/A |
| Revenue Next Year | $186.30 | N/A |
| P/E Ratio | ★ N/A | $0.91 |
| Revenue Growth | N/A | ★ 6.21 |
| 52 Week Low | $4.09 | $0.50 |
| 52 Week High | $34.27 | $21.18 |
| Indicator | SCLX | MLGO |
|---|---|---|
| Relative Strength Index (RSI) | 39.05 | 59.78 |
| Support Level | $6.20 | $4.30 |
| Resistance Level | $8.18 | $4.47 |
| Average True Range (ATR) | 1.38 | 0.32 |
| MACD | -0.32 | 0.03 |
| Stochastic Oscillator | 1.16 | 71.23 |
Scilex Holding Co is focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. It targets indications with high unmet needs and large market opportunities with non-opioid therapies for the treatment of patients with acute and chronic pain and are dedicated to advancing and improving patient outcomes. Its commercial products are: ZTlidoO for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a potential first-line treatment ready-to-use oral solution for the acute treatment of migraine in adults and GLOPERBA, the liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults.
MicroAlgo Inc is engaged in the development and application of bespoke central processing algorithms and provides solutions by integrating these algorithms with software or hardware, or both, to streamline digital services. Its services include algorithm optimization, accelerating computing power without hardware upgrades, lightweight data processing, and data intelligence services. Its technology and solutions are mainly in internet multimedia video advertising, where it provides advertising distribution solutions, software services, comprehensive solutions for enterprise customers, and intelligent chips solutions. It derives revenue from central processing algorithm services for internet advertisement and intelligent chips and services, with maximum revenue generated from Mainland PRC.